Can Prostate Specific Antigen Derivatives and Pathological Parameters Predict Significant Change in Expectant Management Criteria for Prostate Cancer?-Reference-Cited by-同舟云学术

Can Prostate Specific Antigen Derivatives and Pathological Parameters Predict Significant Change in Expectant Management Criteria for Prostate Cancer?

Published:2003-12 Issue:6 Volume:170 Page:2274-2278
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

KHAN MASOOD A.¹,CARTER H. BALLENTINE¹,EPSTEIN JONATHAN I.¹,MILLER MICHAEL C.¹,LANDIS PATRICIA¹,WALSH PATRICK W.¹,PARTIN ALAN W.¹,VELTRI ROBERT W.¹

Affiliation:

1. From the James Buchanan Brady Urological Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland, and Quakertown, Pennsylvania (MCM)

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference20 articles.

1. Cancer statistics, 2001;Greenlee;CA Cancer J Clin,2001

2. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer;Epstein;JAMA,1994

3. Prospective characterization of pathological features of prostatic carcinomas detected via serum prostate specific antigen based screening;Humphrey;J Urol,1996

4. Prospective evaluation of men with stage T1c adenocarcinoma of the prostate;Carter;J Urol,1997

5. Expectant management of nonpalpable prostate cancer with curative intent: preliminary results;Carter;J Urol,2002

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Digital versus Analog 68Ga-PSMA-11 PET/CT Performance in Hormone-Sensitive Prostate Cancer Patients with Early Biochemical Recurrence or Persistence after Radical Treatment;Diagnostics;2023-11-26

2. Application of 18F-PSMA-1007 PET/MR Imaging in Early Biochemical Recurrence of Prostate Cancer: Results of a Prospective Study of 60 Patients with Very Low PSA Levels ≤ 0.5 ng/mL;Cancers;2023-08-20

3. Mapping the Oncological Basis Dataset to the Standardized Vocabularies of a Common Data Model: A Feasibility Study;Cancers;2023-08-11

4. Prostate-Specific Membrane Antigen Expression on PET/CT in Patients with Metastatic Castration-Resistant Prostate Cancer: A Retrospective Observational Study;Journal of Nuclear Medicine;2023-01-12

5. Predictors of Bone Metastases at 68Ga-PSMA-11 PET/CT in Hormone-Sensitive Prostate Cancer (HSPC) Patients with Early Biochemical Recurrence or Persistence;Diagnostics;2022-05-24